Division of System Cohort, Multi-scale Research Center for Medical Science, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, Fukuoka 812-8582, Japan.
J Chem Inf Model. 2012 Dec 21;52(12):3284-92. doi: 10.1021/ci2005548. Epub 2012 Dec 4.
Drug side-effects, or adverse drug reactions, have become a major public health concern and remain one of the main causes of drug failure and of drug withdrawal once they have reached the market. Therefore, the identification of potential severe side-effects is a challenging issue. In this paper, we develop a new method to predict potential side-effect profiles of drug candidate molecules based on their chemical structures and target protein information on a large scale. We propose several extensions of kernel regression model for multiple responses to deal with heterogeneous data sources. The originality lies in the integration of the chemical space of drug chemical structures and the biological space of drug target proteins in a unified framework. As a result, we demonstrate the usefulness of the proposed method on the simultaneous prediction of 969 side-effects for approved drugs from their chemical substructure and target protein profiles and show that the prediction accuracy consistently improves owing to the proposed regression model and integration of chemical and biological information. We also conduct a comprehensive side-effect prediction for uncharacterized drug molecules stored in DrugBank and confirm interesting predictions using independent information sources. The proposed method is expected to be useful at many stages of the drug development process.
药物副作用或药物不良反应已成为一个主要的公共卫生关注点,并且仍然是药物失败和一旦进入市场就被撤回的主要原因之一。因此,识别潜在的严重副作用是一个具有挑战性的问题。在本文中,我们开发了一种新的方法,基于候选药物分子的化学结构和靶蛋白信息,大规模预测潜在的副作用特征。我们提出了几种针对多响应的核回归模型扩展,以处理异质数据源。其创新性在于将药物化学结构的化学空间和药物靶蛋白的生物学空间整合到一个统一的框架中。结果表明,我们在同时预测 969 种已批准药物的副作用方面证明了该方法的有效性,这些副作用是基于它们的化学亚结构和靶蛋白特征来预测的,并且由于提出的回归模型和化学与生物学信息的整合,预测准确性得到了一致提高。我们还对 DrugBank 中存储的未表征药物分子进行了全面的副作用预测,并使用独立的信息源对有趣的预测进行了验证。该方法有望在药物开发过程的许多阶段都有用处。